Phase II trial of sorafenib (BAY 43-9006) in malignant mesothelioma: CALGB 30307 Meeting Abstract
| Authors: | Jänne, P. A.; Wang, X. F.; Krug, L. M.; Hodgson, L.; Vokes, E. E.; Kindler, H. L. |
| Abstract Title: | Phase II trial of sorafenib (BAY 43-9006) in malignant mesothelioma: CALGB 30307 |
| Meeting Title: | 31st ESMO Congress |
| Journal Title: | Annals of Oncology |
| Volume: | 17 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2006 Sep 29-Oct 3 |
| Meeting Location: | Istanbul, Turkey |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2006-09-01 |
| Start Page: | ix216 |
| End Page: | ix217 |
| Language: | English |
| ACCESSION: | WOS:000248078900735 |
| PROVIDER: | wos |
| PUBMED: | 17018761 |
| DOI: | 10.1093/annonc/mdl216 |
| Notes: | Meeting Abstract: 723PD - 30th Congress of the European-Society-for-Medical-Oncology - SEP 29-OCT 03, 2006 - Istanbul, TURKEY - "Source: Wos" |
